<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04692987</url>
  </required_header>
  <id_info>
    <org_study_id>FF-2020-155</org_study_id>
    <nct_id>NCT04692987</nct_id>
  </id_info>
  <brief_title>Effectiveness of Decision-aid Video on Colorectal Cancer Screening</brief_title>
  <acronym>DAVOCS</acronym>
  <official_title>Effectiveness of Decision-aid Video on Colorectal Cancer Screening in Primary Healthcare Setting: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universiti Kebangsaan Malaysia Medical Centre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universiti Kebangsaan Malaysia Medical Centre</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Colorectal cancer (CRC) is the second most common cancer in Malaysia. Diagnosing CRC at early&#xD;
      stage is crucial to reduce their mortality risk. To achieve this aim, CRC screening promotion&#xD;
      intervention is deemed necessary.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      High-quality CRC screening interventions and approaches should be delivered to a large&#xD;
      proportion of target population.&#xD;
&#xD;
      To our knowledge, there is no interactive video been developed, that can be used as&#xD;
      educational tool for CRC screening in Malaysia. By developing an educational video, we hope&#xD;
      that it can be used by health professionals to promote CRC screening, favoring their&#xD;
      empowerment for prevention and control of disease.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 2021</start_date>
  <completion_date type="Anticipated">March 2022</completion_date>
  <primary_completion_date type="Anticipated">September 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Parallel randomized controlled trial will be conducted in 3 months duration, with intention-to-treat.</intervention_model_description>
    <primary_purpose>Screening</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
    <masking_description>Investigators will designate participants to which arm using random sampling. Participants and care providers are masked to which arm they receive.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Number of participants with colorectal cancer screening completion</measure>
    <time_frame>3 months</time_frame>
    <description>Number of participants with completion of fecal occult blood test or colonoscopy procedures by participants</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of participants with colonoscopy completion among those with positive fecal occult blood test</measure>
    <time_frame>3 months</time_frame>
    <description>Number of participants who are completed colonoscopy among those positive fecal occult blood test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Period time from intervention to fecal occult blood test uptake</measure>
    <time_frame>3 months</time_frame>
    <description>Duration taken after received intervention to screening uptake</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Barriers towards the colorectal cancer screening uptake</measure>
    <time_frame>3 months</time_frame>
    <description>List of barriers (numbers) towards the colorectal cancer screening uptake</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Colorectal Cancer</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will receive decision-aid video</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Participants will receive usual care</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Decision-aid video</intervention_name>
    <description>Decision-aid video will be developed to disseminate knowledge and to raise awareness on colorectal cancer screening</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Malaysian aged 50 - 74 years old&#xD;
&#xD;
          -  No previous history or family history of CRC&#xD;
&#xD;
          -  Asymptomatic of CRC&#xD;
&#xD;
          -  Never participated in CRC screening&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Acute patients&#xD;
&#xD;
          -  Patients on aspirin, warfarin or any blood-thinning agent&#xD;
&#xD;
          -  Illiterate or having a significant vision or hearing impairment&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>74 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Azmawati Mohammed Nawi</last_name>
    <role>Principal Investigator</role>
    <affiliation>The National University of Malaysia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Azmawati Mohammed Nawi, Medical</last_name>
    <phone>+6 03 8921 5555340</phone>
    <email>azmawati@ppukm.ukm.edu.my</email>
  </overall_contact>
  <location>
    <facility>
      <name>The National University of Malaysia</name>
      <address>
        <city>Cheras</city>
        <state>Kuala Lumpur</state>
        <zip>56000</zip>
        <country>Malaysia</country>
      </address>
    </facility>
    <contact>
      <last_name>Azmawati Mohammed Nawi</last_name>
    </contact>
    <investigator>
      <last_name>Nur Suhada Ramli</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mohd Rohaizat Hassan</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Zhiqin Wong</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Muhamad Izwan Ismail</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Faiz Daud</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Emma Mirza Wati Mohamad</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Arina Anis Azlan</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Noor Azimah Muhammad</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Malaysia</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>December 22, 2020</study_first_submitted>
  <study_first_submitted_qc>December 30, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 5, 2021</study_first_posted>
  <last_update_submitted>December 30, 2020</last_update_submitted>
  <last_update_submitted_qc>December 30, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universiti Kebangsaan Malaysia Medical Centre</investigator_affiliation>
    <investigator_full_name>Azmawati</investigator_full_name>
    <investigator_title>Public Health Specialist &amp; Medical Lecturer</investigator_title>
  </responsible_party>
  <keyword>Screening</keyword>
  <keyword>Primary care</keyword>
  <keyword>Video</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Only three principal investigators will have access to participants' data</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

